Journal of Genetic Syndromes & Gene Therapy
Open Access

Natalay Y Kouprina

Biography

Dr. Natalay Kouprina received her M.Sc. in physical chemistry from the St. Petersburg State University, Russia, and her Ph.D. and Dr.Sc. in cell biology from the Institute of Cytology, Russian Academy of Sciences. While in Russia, she worked on the identification of genes that control the replication and segregation of chromosomes in budding yeast. In 1991 she moved to the United States and focused her interests on genomics. At present she is a staff scientist at the National Cancer Institute, USA. Her current interest is to combine a transformation-associated recombination (TAR) cloning technology that allows selective isolation of a gene of interest up to 300 kb in size from complex genomes, including humans, with the human artificial chromosome or HAC-based gene delivery vector to develop a novel system for the delivery and expression of full-length mammalian genes. Such a novel approach has a potential for gene functional studies and gene therapy. She has 83 publications in many leading journals. Also, she is the inventor of several patents, some exclusively licensed by a private sector. Presently, she serves as Editorial Board Member of 3 other referred journals.

Research Interest

Dr. Natalay Kouprina current interest is to combine a transformation-associated recombination (TAR) cloning technology that allows selective isolation of a gene of interest up to 300 kb in size from complex genomes, including humans, with the human artificial chromosome or HAC-based gene delivery vector to develop a novel system for the delivery and expression of full-length mammalian genes.